Your cart
Your cart is empty
Continue shopping
Low stock
In stock, ready to ship
Product Sold Out
More Information (Symbion / 20mg/0.2mL)
Active Ingredients
Enoxaparin Sodium 20mg/0.2mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 20mg/0.2mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (Symbion / 40mg/0.4mL)
Active Ingredients
Enoxaparin Sodium 40mg/0.4mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 40mg/0.4mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (Symbion / 60mg/0.6mL)
Active Ingredients
Enoxaparin Sodium 60mg/0.6mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 60mg/0.6mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (Symbion / 80mg/0.8mL)
Active Ingredients
Enoxaparin Sodium 80mg/0.8mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 80mg/0.8mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (Symbion / 100mg/mL)
Active Ingredients
Enoxaparin Sodium 100mg/mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 100mg/mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (Symbion / 120mg/0.8mL)
Active Ingredients
Enoxaparin Sodium 120mg/0.8mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 120mg/0.8mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (Symbion / 150mg/mL)
Active Ingredients
Enoxaparin Sodium 150mg/mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 150mg/mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 20mg/0.2mL)
Active Ingredients
Enoxaparin Sodium 20mg/0.2mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 20mg/0.2mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 40mg/0.4mL)
Active Ingredients
Enoxaparin Sodium 40mg/0.4mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 40mg/0.4mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 60mg/0.6mL)
Active Ingredients
Enoxaparin Sodium 60mg/0.6mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 60mg/0.6mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 80mg/0.8mL)
Active Ingredients
Enoxaparin Sodium 80mg/0.8mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 80mg/0.8mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 100mg/mL)
Active Ingredients
Enoxaparin Sodium 100mg/mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 100mg/mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 120mg/0.8mL)
Active Ingredients
Enoxaparin Sodium 120mg/0.8mL
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 120mg/0.8mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
More Information (CH2 / 150mg/mL)
Active Ingredients
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Free-From
Indicators
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.
Prevention of thrombosis in extra-corporeal circulation due to haemodialysis.
Treatment of established deep vein thrombosis.
Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Tablet Description
Clear, colourless to pale yellow solution free from visible particles in a prefilled syringe.
Storage Conditions
Store below 25 degrees celsius. Do not freeze.
Additional Information
- Generic Name: Enoxaparin
- PBS Listed: ✘
- RPBS: ✘
- Strength: 150mg/mL
- Dosage: Injection, solution
- Pack Size: 10
- Schedule: S4
- Shelf Life: 36 Months
- Innovator: Clexane
Warnings
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.
